Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,908 | -5,895 | -2,845 | -14,288 | -12,051 |
| Depreciation Amortization | 27 | 23 | 11 | 45 | 32 |
| Other Working Capital | 1,169 | 1,044 | 645 | -1,716 | -1,603 |
| Other Operating Activity | 524 | 144 | 80 | 731 | 827 |
| Operating Cash Flow | $-6,188 | $-4,685 | $-2,109 | $-15,229 | $-12,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 64 | N/A | N/A | -116 | -112 |
| Investing Cash Flow | $64 | $N/A | $N/A | $-116 | $-112 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -564 | N/A |
| Common Stock Issued | 850 | N/A | N/A | 69 | N/A |
| Other Financing Activity | -385 | -268 | -160 | 0 | -407 |
| Financing Cash Flow | $465 | $-268 | $-160 | $-495 | $-407 |
| Beginning Cash Position | 11,427 | 11,427 | 11,427 | 27,266 | 27,266 |
| End Cash Position | 5,767 | 6,474 | 9,158 | 11,427 | 13,951 |
| Net Cash Flow | $-5,660 | $-4,953 | $-2,268 | $-15,839 | $-13,315 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,188 | -4,685 | -2,109 | -15,229 | -12,796 |
| Capital Expenditure | N/A | N/A | N/A | -128 | -124 |
| Free Cash Flow | -6,188 | -4,685 | -2,109 | -15,356 | -12,920 |